Abstract
In order to determine whether the A cell may be directly suppressed by glucose in the absence of insulin, canine pancreata were perfused in vitro, both antegrade, through the arterial system and retrograde, through the venous system. Studies of the islet microvasculature have suggested that blood flows from the B cell core to the mantle; thus, the A cell may be tonically inhibited by intra-islet insulin. Retrograde perfusion may then be expected to prevent insulin from reaching the A cell, releasing it from inhibition. Retrograde perfusion with 88 mg/dl glucose markedly increased both insulin and glucagon secretion relative to antegrade levels. In a series of experiments, glucose concentrations were changed from 88 to 200 mg/dl. An antegrade glucose change resulted in increased insulin (134+/-21%; P less than 0.0025) and decreased glucagon (-26+/-9%, P less than 0.025) secretion. A retrograde glucose increase resulted in increased secretion of both insulin (91+/-15%; P less than 0.0005) and glucagon (23+/-9%; P less than 0.0125). To confirm that retrograde perfusion deprived the A cell of endogenous core derived, vascularly delivered insulin, possibly resulting in increased insulin sensitivity, 0.3 mU/ml exogenous porcine insulin was infused. Antegrade, 0.3 mU/ml insulin, had no effect on glucagon secretion (P less than 0.250), while retrograde infusion of 0.3 mU/ml insulin significantly inhibited glucagon secretion (-31 + 8%; P less than 0.0005). The results of our study support the concept that the direction of blood flow and of flow-dependent intra-islet hormone interactions are from the islet B cell core to the mantle. It was further concluded that the normal A cell may not be suppressed by glucose in the absence of insulin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Asplin C. M., Paquette T. L., Palmer J. P. In vivo inhibition of glucagon secretion by paracrine beta cell activity in man. J Clin Invest. 1981 Jul;68(1):314–318. doi: 10.1172/JCI110251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Asplin C., Raghu P., Dornan T., Palmer J. P. Glucose regulation of glucagon secretion independent of B cell activity. Metabolism. 1983 Mar;32(3):292–295. doi: 10.1016/0026-0495(83)90195-6. [DOI] [PubMed] [Google Scholar]
- Assan R., Efendic S., Luft R., Cerasi E. Dose-kinetics of pancreatic glucagon responses to arginine and glucose in subjects with normal and impaired pancreatic B cell function. Diabetologia. 1981 Nov;21(5):452–459. doi: 10.1007/BF00257785. [DOI] [PubMed] [Google Scholar]
- Bonner-Weir S., Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes. 1982 Oct;31(10):883–889. doi: 10.2337/diab.31.10.883. [DOI] [PubMed] [Google Scholar]
- Braaten J. T., Faloona G. R., Unger R. H. The effect of insulin on the alpha-cell response to hyperglycemia in long-standing alloxan diabetes. J Clin Invest. 1974 Apr;53(4):1017–1021. doi: 10.1172/JCI107638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hermansen K., Orskov H., Christensen S. E. Streptozotocin diabetes: a glucoreceptor dysfunction affecting D cells as well as B and A cells. Diabetologia. 1979 Dec;17(6):385–389. doi: 10.1007/BF01236274. [DOI] [PubMed] [Google Scholar]
- Maruyama H., Hisatomi A., Orci L., Grodsky G. M., Unger R. H. Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest. 1984 Dec;74(6):2296–2299. doi: 10.1172/JCI111658. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stagner J. I., Samols E. Perturbation of insulin oscillations by nerve blockade in the in vitro canine pancreas. Am J Physiol. 1985 May;248(5 Pt 1):E516–E521. doi: 10.1152/ajpendo.1985.248.5.E516. [DOI] [PubMed] [Google Scholar]
- Unger R. H. The Berson memorial lecture. Insulin-glucagon relationships in the defense against hypoglycemia. Diabetes. 1983 Jun;32(6):575–583. doi: 10.2337/diab.32.6.575. [DOI] [PubMed] [Google Scholar]
- Unger R. H. The milieu interieur and the islets of Langerhans. Diabetologia. 1981;20(1):1–11. doi: 10.1007/BF00253809. [DOI] [PubMed] [Google Scholar]
- Weir G. C., Samols E., Loo S., Patel Y. C., Gabbay K. H. Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine. Diabetes. 1979 Jan;28(1):35–40. [PubMed] [Google Scholar]